logo
Sign in

CDXI Stock Price, Chart, Stats & News

Cardax, Inc.
Save

Cardax, Inc. (CDXI) does not currently pay a dividend.

80
Market cap
Current P/E
Forward P/E

CDXI chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels.

Similar securities

Based on sector and market capitalization

Report issue